Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyle Jensen

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 23, 2019
Efficacy of Fecal Microbiota Transplantation for Clostridium difficile Infection in ChildrenMaribeth R Nicholson, Paul D Mitchell, Erin Alexander, et al.
Journal of Crohn'S & Colitis|November 17, 2021
Efficacy and Outcomes of Faecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection in Children with Inflammatory Bowel DiseaseMaribeth R Nicholson, Erin Alexander, Sonia Ballal, et al.
Hepatology Communications|April 1, 2026
CD8 TRM-like T cells expressing perforin and IFN-γ define a pediatric activated T-cell acute liver failure endotypeTamir Diamond, Catherine A Chapin, Caroline J Diorio, et al.
Hepatology (Baltimore, Md.)|September 18, 2020
Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched AnalysisMark R Deneau, Cara Mack, Douglas Mogul, et al.
Alimentary Pharmacology & Therapeutics|March 11, 2024
Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC ConsortiumAmanda Ricciuto, Kuan Liu, Wael El-Matary, et al.
Hepatology (Baltimore, Md.)|April 9, 2017
The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaborationMark R Deneau, Wael El-Matary, Pamela L Valentino, et al.
Hepatology (Baltimore, Md.)|May 29, 2020
The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) Index: A Prognostic Tool for ChildrenMark R Deneau, Cara Mack, Emily R Perito, et al.
Hepatology (Baltimore, Md.)|September 7, 2022
Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver diseaseDaniel H Leung, Sridevi Devaraj, Nathan P Goodrich, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 18, 2025
Elevated Serum Bile Acids Predict Poor Liver Outcomes in Children With Alagille Syndrome: Results From the GALA Study GroupCarla Fiorella Murillo Perez, Shannon M Vandriel, Emmanuel M Gonzales, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 31, 2025
Phenotypic Divergence of JAG1- and NOTCH2-Associated Alagille Syndrome & Disease-Specific NOTCH2 Variant Classification GuidelinesShannon M Vandriel, Li-Ting Li, Huiyu She, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 23, 2019
Efficacy of Fecal Microbiota Transplantation for Clostridium difficile Infection in ChildrenMaribeth R Nicholson, Paul D Mitchell, Erin Alexander, et al.
Journal of Crohn'S & Colitis|November 17, 2021
Efficacy and Outcomes of Faecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection in Children with Inflammatory Bowel DiseaseMaribeth R Nicholson, Erin Alexander, Sonia Ballal, et al.
Hepatology Communications|April 1, 2026
CD8 TRM-like T cells expressing perforin and IFN-γ define a pediatric activated T-cell acute liver failure endotypeTamir Diamond, Catherine A Chapin, Caroline J Diorio, et al.
Hepatology (Baltimore, Md.)|September 18, 2020
Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched AnalysisMark R Deneau, Cara Mack, Douglas Mogul, et al.
Alimentary Pharmacology & Therapeutics|March 11, 2024
Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC ConsortiumAmanda Ricciuto, Kuan Liu, Wael El-Matary, et al.
Hepatology (Baltimore, Md.)|April 9, 2017
The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaborationMark R Deneau, Wael El-Matary, Pamela L Valentino, et al.
Hepatology (Baltimore, Md.)|May 29, 2020
The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) Index: A Prognostic Tool for ChildrenMark R Deneau, Cara Mack, Emily R Perito, et al.
Hepatology (Baltimore, Md.)|September 7, 2022
Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver diseaseDaniel H Leung, Sridevi Devaraj, Nathan P Goodrich, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 18, 2025
Elevated Serum Bile Acids Predict Poor Liver Outcomes in Children With Alagille Syndrome: Results From the GALA Study GroupCarla Fiorella Murillo Perez, Shannon M Vandriel, Emmanuel M Gonzales, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 31, 2025
Phenotypic Divergence of JAG1- and NOTCH2-Associated Alagille Syndrome & Disease-Specific NOTCH2 Variant Classification GuidelinesShannon M Vandriel, Li-Ting Li, Huiyu She, et al.
Pageof 7